|
|
|
市場調查報告書
核酸檢測市場
Nucleic Acid Testing
|
核酸檢測市場 是由出版商Global Industry Analysts, Inc.在2010年06月所出版的。
這份英文市場調查報告書包含Pages: 377 價格從美金3950起跳。
本報告為，分析全球核酸檢測市場，並匯整核酸檢測概要及應用領域、產品概要、全球地區別市場、企業施策趨勢，以下列摘要形式闡述。
第1章 簡介、調查方式、產品定義
第2章 實施概要
- 市場概要
- 簡介
- 現況及未來分析
- 核酸檢測市場概要
- 重點照護酸檢測
- 替代重點照護酸檢測之側流向平台
- 市場趨勢
- 獸醫界注重於核酸檢測試劑盒及免疫診斷
- 自家方式持續獨占NAPI市場
- 分子診斷：未開發領域
- 低價產品受歡迎
- 新應用及技術拓展核酸隔離方式之顧客群
- FDA許可了C型肝炎及HIV於監測時使用核酸檢測
- 其他類監測時核酸檢測之使用及FDA認可之輸血
- 產品概要
- 何謂核酸檢測
- 核酸檢測之應用
- 核酸檢測之作業順序
- 活用技術驅力
- 核酸側流向發現方式
- 多元性核酸檢測
- 地區別市場展望
- 近年市場活動
- 產品上市
- DaAn Gene發售用於新流感H1N1病毒之核酸檢測
- Sequenom發售SensiGene囊性纖維化篩選試驗
- Jeevan開售核酸檢測
- 企業策略性對策
- 其他開發
- 主要企業
- Abbott Laboratories, Inc.
- Agilent Life Sciences and Chemical Analysis
- Applied Biosystems Group
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Cepheid, Inc.
- Genomic Health, Inc.
- Gen-Probe Inc.
- Genzyme Corp.
- Genzyme Genetics
- Myriad Genetics, Inc.
- Novartis AG
- QIAGEN NV
- Roche Diagnostics
- Siemens Healthcare Diagnostics, Inc.
- Third Wave Technologies, Inc.
- 全球市場展望
第3章 競合情況
- 企業簡介：46間
- 美國
- 加拿大
- 歐洲
- 亞太地區(日本外)
- 拉丁美洲
- 中東
Abstract
This report analyzes the Global market for Nucleic Acid Testing in US$
Million. Annual estimates and forecasts are provided for the period 2006
through 2015. The report profiles 46 companies including many key and niche
players such as Abbott Laboratories, Inc., Agilent Life Sciences and Chemical
Analysis, Applied Biosystems Group, Becton, Dickinson and Company, Bio-Rad
Laboratories, Inc., Cepheid, Inc., Genomic Health, Inc., Gen-Probe Inc.,
Genzyme Corp., Genzyme Genetics, Myriad Genetics, Inc., Novartis AG, QIAGEN
NV, Roche Diagnostics, Siemens Healthcare Diagnostics, Inc., and Third Wave
Technologies, Inc. Market data and analytics are derived from primary and
secondary research. Company profiles are mostly extracted from URL research
and reported select online sources.
Table of Contents
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
- Study Reliability and Reporting Limitations
- Disclaimers
- Data Interpretation & Reporting Level
- Quantitative Techniques & Analytics
- Product Definitions and Scope of Study
- Nucleic Acid Test
- Polymerase Chain Reaction or PCR Tests
- Reverse Transcriptase PCR or RT-PCR Tests
- Branched DNA or Quantiplex bDNA Tests
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Introduction
- Current and Future Analysis
- A Glance at the Nucleic Acid Testing Market
- Point of Care (POC) Nucleic Acid Tests
- Lateral Flow Platform-An Alternative to POC Nucleic Acid Testing
2. MARKET TRENDS
- Veterinary Industry Eyes on Nucleic Acid Testing Kits and Immunodiagnostics
- Home-Brewing Methods Continue to Dominate the NAPI Markets
- Molecular Diagnostics - A Largely Untapped Market
- Low-Priced Commercial Products to Mar the Popularity of Conventional
Nucleic Acid Isolation Methods
- Novel Applications and Technologies Widen Customer Base for Nucleic Acid
Isolation Processes
- FDA Licenses Nucleic Acid Tests Usage for Screening Hepatitis C and HIV
- Usage of NAT for Screening Additional Categories of HIV in Tissues and
Donated Blood Approved by FDA
3. PRODUCT OVERVIEW
- What is a Nucleic Acid Test?
- Polymerase Chain Reaction or PCR Tests
- Reverse Transcriptase PCR or RT-PCR Tests
- Branched DNA or Quantiplex bDNA Tests
- Applications of NAT
- NAT for Hepatitis C Virus Infection (HCV)
- Qualitative Tests
- Clinical Uses of Qualitative Nucleic Acid Test
- Quantitative Tests
- Real-Time PCR Method
- Use of NAA for Diagnosing Tuberculosis
- Factors Hindering the Adoptability of NAA Tests for Tuberculosis
- Use of NAA for Diagnosing STI
- Use of Nucleic Acid Sequence-Based Amplification for Diagnosing Dengue
Viral RNA
- Segments of NAT Technology
- Amplified Probe Technology
- Signal Amplification
- Probe Amplification
- Target Amplification
- Direct Nucleic Acid Probes
- Types of Techniques
- In-situ hybridization (ISH)
- Southern Blot
- Liquid Hybridization
- Working Procedure of Nucleic Acid Tests
- Impediments for Using Technology
- Capturing Methods for Discovering Nucleic Acid Lateral Flow (NALF)
- Multiplex Nucleic Acid Testing
4. REGIONAL MARKET PERSPECTIVE
4a. THE UNITED STATES
- A. Market Analysis
- Outlook
- A Snapshot of the US Nucleic Acid Testing Market
- Soaring Demand from Various Applications Drives the US NAPI Market
- Use of NAT in STDs and HPV
- B. Market Analytics
- Table 1: US Recent Past, Current & Future Analysis for Nucleic Acid
Testing Markets with Annual Revenues in US$ Million for Years 2006 through
2015 (includes corresponding Graph/Chart)
4b. REST OF WORLD
- A. Market Analysis
- Outlook
- Overview of Select Regional Markets
- Europe
- A Glance at the Europe' s Nucleic Acid Testing and Blood Safety Market
- Table 2: European Recent Past, Current & Future Analysis for Nucleic
Acid-based Amplification Reagents Markets by Geographic Region-France,
Germany, Italy, UK, Spain and Rest of Europe Markets Independently Analyzed
with Annual Revenues in US$ Million for Years 2006 through 2015 (includes
corresponding Graph/Chart)
- Table 3: European 10-Year Perspective for Nucleic Acid-based
Amplification Reagents by Geographic Region - Percentage Breakdown of
Revenues for France, Germany, Italy, UK, Spain and Rest of Europe Markets
for 2006, 2009 & 2015 (includes corresponding Graph/Chart)
- Table 4: European Recent Past, Current & Future Analysis for Nucleic
Acid-based Amplification Reagents by Segment- Genetic Testing, Infectious
Diseases and Transplant Diagnostics Markets Independently Analyzed with
Annual Revenues in US$ Million for Years 2006 through 2015 (includes
corresponding Graph/Chart)
- Table 5: European 10-Year Perspective for Nucleic Acid-based
Amplification Reagents by Segment - Percentage Breakdown of Revenues for
Genetic Testing, Infectious Diseases and Transplant Diagnostics Markets for
2006, 2009 & 2015 (includes corresponding Graph/Chart)
- China
- Chinese Nucleic Acid Testing Market: An Overview
- B. Market Analytics
- Table 6: Rest of World Recent Past, Current & Future Analysis for
Nucleic Acid Testing Markets with Annual Revenues in US$ Million for Years
2006 through 2015 (includes corresponding Graph/Chart)
5. PRODUCT LAUNCHES
- DaAn Gene Unveils Nucleic Acid Testing Kit for Influenza A H1N1 Virus
- Sequenom Launches SensiGene Cystic Fibrosis Carrier Screening Test
- Jeevan Introduces Nucleic Acid Testing
6. STRATEGIC CORPORATE DEVELOPMENTS
- Gen-Probe Acquires Prodesse
- STRATEC Takes Over Invitek
- Becton, Dickinson and Company Takes Over Handy Lab
- Gen-Probe Acquires Tepnel Life Sciences
- Micronics and Biosearch Technologies Ink Licensing Agreement
- Quidel and BioHelix Sign Agreement
- BlueGnome Signs Agreement with Rubicon Genomics
- DaAn Gene to Setup Four Joint Ventures
- Gen-Probe and Chiron to Extend Partnership
- EnviroLogix Inks Licensing Agreement with Ionian Technologies
- HandyLab Extends Partnership with Epoch Biosciences
- QIAGEN to Provide Molecular Testing Solutions to Bio-Manguinhos
- Nanogen Signs Licensing and Supply Agreement with HandyLab
- Blood System Laboratories and Florida Blood Services Establish a Joint
Venture
- Teva Collaborates with Compugen
- QIAGEN Takes-Over Biotage' s Biosystems Unit
- QIAGEN Snaps Up Corbett Life Science
- Agilent Technologies to Expand API Manufacturing Plant
- Polyclone Bioservices to Establish Nucleic Acid Testing Units in India
- Pacgen Biopharmaceuticals Signs LoI with Medigen Biotechnology
- easyDNA Establishes New DNA Testing Center in India
- Apollo Chennai Establishes Nucleic Acid Testing Unit
7. OTHER DEVELOPMENTS
- Nanosphere Receives FDA Approval for Respiratory Virus Assay
- Roche Diagnostics Obtains FDA Approval for Broader Usage of Nucleic Acid
Test
- US and European Patent Authorities Award Patents to Gen-Probe for NAT
- The National Institute of Allergy and Infectious Diseases Awards $770,000
to Micronics
- DaAn Gene Obtains SFDA Approval for Marketing Nucleic Acid Test Kits
- Luminex Molecular Diagnostics xTAG Respiratory Viral Panel Approved by FDA
- Siemens Healthcare' s Apple iMac OSX Operating System Approved by FDA
- Micronics Receives NIH Grant for Developing HIV POC Test
8. FOCUS ON SELECT PLAYERS
- Abbott Laboratories, Inc. (US)
- Agilent Life Sciences and Chemical Analysis (US)
- Applied Biosystems Group (US)
- Becton, Dickinson and Company (US)
- Bio-Rad Laboratories, Inc. (US)
- Cepheid, Inc. (US)
- Genomic Health, Inc. (US)
- Gen-Probe Inc. (US)
- Genzyme Corp. (US)
- Genzyme Genetics (US)
- Myriad Genetics, Inc. (US)
- Novartis AG (Switzerland)
- QIAGEN NV (Netherlands)
- Roche Diagnostics (US)
- Siemens Healthcare Diagnostics, Inc. (US)
- Third Wave Technologies, Inc. (US)
9. GLOBAL MARKET PERSPECTIVE
- Table 7: World Recent Past, Current & Future Analysis for Nucleic Acid
Testing by Geographic Region - US and Rest of World Markets Independently
Analyzed with Annual Revenues in US$ Million for Years 2006 through 2015
(includes corresponding Graph/Chart)
- Table 8: World 10-Year Perspective for Nucleic Acid Testing by Geographic
Region -Percentage Breakdown of Revenues for US and Rest of World Markets for
2006, 2009 & 2015
III. COMPETITIVE LANDSCAPE
|
 |
